Immuno Oncology Combination Therapies With IL-2 Conjugates

    公开(公告)号:US20210046160A1

    公开(公告)日:2021-02-18

    申请号:US16993967

    申请日:2020-08-14

    申请人: Synthorx, Inc.

    IPC分类号: A61K38/20 A61K47/68

    摘要: Disclosed herein are compositions, kits, and methods comprising interleukin (IL) conjugates (e.g., IL-2 conjugates) in combination with other agents or methods useful for the treatment of one or more indications, such as the treatment of proliferative diseases. Also described herein are pharmaceutical compositions and kits comprising one or more of the interleukin conjugates (e.g., IL-2 conjugates).